GlycoEra
GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.
GlycoEra is active in the biotechnology space based in Europe, Middle East, and Africa (EMEA), founded in 2020.
GlycoEra is positioned in biotechnology, a segment that rewards a clear, focused offering.
The business is associated with Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_A stage.
Its team size is recorded as c_00011_00050 employees.
Public records show total funding of about $45M.
| Sector | Biotechnology |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $45,000,000 |
Website: glycoera.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account